Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TTD vs GSK✓SelectedUSD · GSKTTD vs GSK performance historyLatest closeAs of+3.95%11/18
Stock and ETF performance explorer

TTD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-76.9%
GSK return
+56.0%
Excess return
-132.9%
Maximum drawdown
-91.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+4.0%-1.3%+5.3%+3.9%
7D-2.9%-3.1%+0.2%-2.9%
30D+26.6%-0.9%+27.5%+26.6%
3M+15.6%-4.2%+19.8%+15.3%
6M-30.3%-1.6%-28.7%-30.3%
YTD-59.1%+2.6%-61.7%-59.4%
1Y-61.7%+6.2%-67.9%-62.0%
All-76.9%+56.0%-132.9%-78.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling